Upstream and Downstream Cardiovascular Changes in Rheumatic Mitral Stenosis: An Update

Estu Rudiktyo, Arco J Teske, Emir Yonas, Ade M Ambari, Maarten J Cramer, Marco Guglielmo*, Tommaso Semino, Bambang Budi Siswanto, Pieter A Doevendans, Amiliana M Soesanto

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

Rheumatic heart disease (RHD) and its complications are major health problems worldwide, especially in developing countries, owing to their high prevalence. Mitral stenosis (MS) is one of the most common lesions in RHD, either isolated or in combination with mitral regurgitation, and eventually leads to atrial fibrillation (AF), congestive heart failure, pulmonary hypertension (PH), and other complications, including ischemic stroke or limb ischemia, if not promptly diagnosed and treated. Recent studies have suggested that MS affects the cardiovascular system beyond mere obstructions. The presence of MS in RHD causes significant changes in the cardiovascular system, both upstream and downstream, affecting both the left and right ventricles. Rheumatic MS causes significant structural changes through inflammatory pathways and hemodynamic changes, owing to its obstructive effects. This review aims to discuss the vast changes in the cardiovascular system caused by rheumatic MS.

Original languageEnglish
Article number2639
Number of pages15
JournalJournal of Clinical medicine
Volume14
Issue number8
DOIs
Publication statusPublished - 11 Apr 2025

Fingerprint

Dive into the research topics of 'Upstream and Downstream Cardiovascular Changes in Rheumatic Mitral Stenosis: An Update'. Together they form a unique fingerprint.

Cite this